
Jens Hansen, PhD
About Me
Dr. Hansen is a Research Assistant Professor in the Ravi Iyengar Lab in the Department of Pharmacological Sciences and the Systems Biology Center of New York. He studied Human Medicine at the University of Goettingen, Germany, and received his doctoral degree at the Institute for Biochemistry and Molecular Cell Biology at the same university. After a two year residency at the Institute of Clinical Chemistry and Laboratory Medicine and Clinical Chemistry, University Hospital of Regensburg, Germany, he joined the Iyengar lab as a postdoctoral fellow, where he became a computational biologist.
Language
English
Position
ASSISTANT PROFESSOR | Pharmacological Sciences
Research Topics
Bioinformatics, Cardiovascular, Cell Biology, Computational Biology, Kidney, Neurobiology, Systems Biology
Awards
2008
Best medical dissertation award
Georg-August-University Göttingen, Faculty of Medicine, Germany
Research
Publications
Selected Publications
- Spatial metabolomics and multiomics integration for breakthroughs in precision medicine for kidney disease. Kumar Sharma, Jens Hansen, Katalin Susztak, Livia Eberlin, Christopher R. Anderton, Theodore Alexandrov, Ravi Iyengar. Nature Reviews Nephrology
- predicTox: an integrated database of clinical risk frequencies and human gene expression signatures for cardiotoxic drugs. Jens Hansen, Pedro Martinez, Arjun S. Yadaw, Yuguang Xiong, Rebecca Racz, Michael R. Pacanowski, Laura L. Hopkins, Nicholas M.P. King, Darrell Abernethy, Eric Sobie, Ravi Iyengar. Database : the journal of biological databases and curation
- Deep inflations maintain surfactant function and alveolar fluid balance in lungs with reduced surfactant protein B levels during mechanical ventilation. Maximilian Löwe, Franziska Roeder, Dirk Wedekind, Oliver Dittrich-Breiholz, Jannik Ruwisch, Jens Hansen, Clemens Ruppert, Christoph Wrede, Jan Hegermann, Bradford J. Smith, Lars Knudsen. Journal of Applied Physiology
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Hansen has not yet completed reporting of Industry relationships.
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.